It was found that anti-IL-10 treatment significantly increased the EOS count compared with the MS-treated mice without anti-IL-10 medication (Figures 3(a) and 3(b)), and the isotype control injection did not alter the protective effect of MS (Figure 3(b)). The gene discussed is IL10; the disease is myeloid sarcoma.